NCT02193334View on ClinicalTrials.gov

Phase I/II Study of KP-100IT in Acute Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 21, 2017

Study Completion Date

July 31, 2018

Conditions
Spinal Cord Injuries
Interventions
DRUG

KP-100IT

DRUG

Placebo

Trial Locations (2)

820-8508

Spinal Injuries Center, Iizuka

072-0015

Hokkaido Chuo Rosai Hospital Sekison Center, Bibai

Sponsors
All Listed Sponsors
lead

Kringle Pharma, Inc.

INDUSTRY